Pfizer to Acquire Australian Digital Health Company for $180 Million

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on whatsapp
WhatsApp
Share on telegram
Telegram

Where Ted Talks end, Truth Talks begin.
Defending democracy by defending free speech

Opinion pieces don’t necessarily reflect the position of our news site but of our Opinion writers.

Pfizer to Acquire Australian Digital Health Company for $180 Million

By Alfred Bui

The majority of shareholders of a small digital health company in Brisbane have approved the $180 million (US$121 million) takeover bid from global pharmaceutical giant Pfizer.

During a virtual scheme meeting on Sept. 7, nearly 83 percent of ResApp’s shares were voted in favour of the takeover, which exceeded the 75 percent supermajority required.

While the company still needs court approval, the deal is expected to progress to completion on Sept. 23.

Pfizer will pay 20.8 cents for each share, which is a 131.1 percent premium to ResApp’s closing price on April 8, when the pharmaceutical giant first announced its intention to acquire the Australian company.

Back in July, chief executive Tony Keating said in comments obtained by AAP that Pfizer’s interest was a “huge validation” for both ResApp and the Australian biotech and digital health sector.

ResApp’s Background

ResApp was founded in 2014 to commercialise a technology developed at the University of Queensland with funding from the university, the Bill and Melinda Gates Foundation, and UniQuest.

The main product of the 20-person company is ResAppDx, a smartphone app used to diagnose respiratory diseases.

It acts like a remote stethoscope that provides diagnoses through a machine learning algorithm when patients cough into their phone’s microphone.

Regulators in Australia and Europe have approved the app to be used by clinicians to diagnose respiratory diseases, pneumonia or asthma in telehealth sessions.

The company is now developing an app to diagnose COVID-19 based on cough noises. However, recent testing shows that further improvements are needed.

Meanwhile, The Australian reported that shareholders’ approval of the acquisition brought relief to ResApp directors and executives, given the current situation of the company.

While there initially had been many opposing voices to the takeover, a number of investors changed their stance after it was revealed that the company was constantly losing money.

According to ResApp’s financial report, the company incurred a loss of $7.1 million in the 2022 financial year, up from $6.7 million in 2021.

“I was relieved that Pfizer saw the value of wanting to put the offer up,” ResApp executive director Brian Leedman said, as reported by The Australian.

“There would be a level of embarrassment if the transaction failed because they’re buying a public company that’s immaterial from an acquisitional point of view.”

Opinion pieces don’t necessarily reflect the position of our news site but of our Opinion writers.

*Note We Deliberately Miss Spell Some Words or Add Capital Letters To Get Around Big Tech Censoring.

Support the ANR from as little as $50 – it only takes a minute. If you can, please consider supporting us with a regular amount each month. Thank you.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on whatsapp
WhatsApp
Share on telegram
Telegram

Related News

Where Ted Talks end, Truth Talks begin.
Defending democracy by defending free speech

Subscribe for free to our ANR news emails and access 2 free ebooks plus Reports to share with family and friends about Covid fraud and the danger of the vaccines.

Help us help defend free speech and save democracy from the World Economic Forum planned Totalitarian Great Reset.

and help us expose the Covid Fraudsters

Leave a Reply

Your email address will not be published. Required fields are marked *

Documentary: Died Suddenly (2022)

Play Video

McIntyre Report
Political Talk Show

Episode 155

Episode 154

How you can advertise on Truthbook.social

Help us help defend free speech and save democracy from the World Economic Forum planned Totalitarian Great Reset.

and help us expose the Covid Fraudsters

Ukraine. Military Summary And Analysis 24.11.2022

Raw Report

Ryan Jackson Saw show

in USD

in AUD

in GBP

in CAD

Jamie McIntyre

ANR on

Currency Exchange Rates in AUD

Live and updated every minute of the day

Nurses Speak Out

Get our free News Emails on latest articles, alerts and solutions for both legal templates and ways to help fight back against the Globalists vax Mandates , and health resources to boost your immune system and ways to Protect from deadly EMF 5G radiation and more.

FREE E-BOOKS AND REPORTS ALSO

ANR Meme Report

with Nadine Roberts

Episode 002

21st Century Political System

Play Video

Editor's Pick

Thank you for visiting the
Australian National Review

To continue accessing more articles for free simply enter your email address

TruthTalks business partnership

Ideal for freedom movement activists, influencers, digital nomads, content creators and those who refuse to be silenced and want to expose the Globalists Agenda .

Truth Talks Partner Opportunity

Click here to learn more about this opportunity and how 12 online clients per year can earn you $203,000 USD per annum

Download the Full PDF - THE COVID-19 FRAUD & WAR ON HUMANITY